Skip to content
Friday, March 24, 2023
HealthCare Middle East & Africa Logo 500

No.1 Healthcare & Pharma Industry Magazine for Middle East & Africa

  • HOME
  • TOPICS
    • MERGERS, INVESTMENTS & FUNDING
    • DISEASES UPDATES
    • HOSPITALS
    • PHARMACEUTICALS
    • PEOPLE NEWS
  • THE MAGAZINE
    • About HealthCare Middle East & Africa Magazine
    • PRESS RELEASES
    • SUBSCRIBE TO EMAIL NEWSLETTERS
  • ADVERTISE
  • PROFILES & INTERVIEWS
  • OUR EVENTS
  • CONTACT US
BREAKING NEWS
  • UAE-based AstraGene and Mylab form joint venture to commercialize automated diagnostics
  • Chinese missionaries in Rwanda perform painless normal delivery
  • <strong>OSHCO, VAMED Group to establish a new rehabilitation & long-term care hospital in Riyadh</strong>
  • Uganda launches project to scale up paediatric surgical services in hospitals
  • <strong>Dubai’s state-owned DAHC, Pfizer, AXDEV Group ally to enhance chronic illness care</strong>
  • Macra supports Ministry of Health with US$53,296 cholera materials
  • KFSH&RC to debut its Digital Health Conference in Riyadh
  • NPHCDA launches project to prevent maternal health challenges
  • <strong>Saudi’s KAEC inks health cooperation pact with Dr. Sulaiman Al Habib Medical Group</strong>
  • Africa has the highest global surge in oral diseases - WHO
You are here
  • Home
  • Government, Regulatory & Policy News

Category: Government, Regulatory & Policy News

Dubai’s state-owned DAHC, Pfizer, AXDEV Group ally to enhance chronic illness care

23 March 202323 March 2023

UAE – State-owned Dubai Academic Health Corporation (DAHC), AXDEV Group, and Pfizer have signed a public-private partnership for improving chronic disease management. It follows the emerging trends of world-class healthcare…

Read More

NPHCDA launches project to prevent maternal health challenges

23 March 202323 March 2023

NIGERIA – The National Primary Health Care Development Agency (NPHCDA) has launched the Optimised Client-Centred Services (OptiCCs), to avert maternal health challenges in the country. The Executive Director, NPHCDA, Dr…

Read More

EU pharma industry group calls for competition check on legislative overhaul

22 March 202322 March 2023

BELGIUM — The European Federation of Pharmaceutical Industries and Associations (EFPIA), based in Brussels, has urged the European Commission to conduct a thorough assessment of the impact of its upcoming…

Read More

Parkinson’s drug patent fight carries high stakes for patients, says FTC

22 March 202323 March 2023

USA — The patent dispute between Supernus and Sage Chemical over the Parkinson’s drug Apokyn has caught the attention of the Federal Trade Commission (FTC), which has expressed concerns over…

Read More

FDA removes most doses of Ozempic from drug shortage list after Novo Nordisk resolves supply issues

21 March 202322 March 2023

USA — Novo Nordisk’s Ozempic, a treatment for type 2 diabetes and off-label for weight loss, is no longer on the FDA’s drug shortage list after months of limited supply.…

Read More

UAE-based medical school MBRU earns top-level institutional accreditation

20 March 202320 March 2023

UAE – The Mohammed bin Rashid University of Medicine and Health Sciences (MBRU) has officially received its second accreditation from the Saudi Commission for Health Specialties (SCFHS) in the Kingdom…

Read More

Pfizer recalls over 4 million packages of prescription migraine medicine voluntarily

19 March 202319 March 2023

USA — Pfizer has issued a recall for 4.2 million packages of Nurtec ODT, which is used to treat migraines in adults. The U.S. Consumer Product Safety Commission (CPSC) raised…

Read More

Japan collaborates with Ministry of Health to reduce mortality of newborns

18 March 202318 March 2023

KENYA – The Ministry of Health is collaborating with Japanese engineers on a Vaccination Management System (VMS) that will include biometric technologies. This system aims to improve the survival rates…

Read More

Covid-19 pill delivered to high-risk patients in four African countries through Quick Start Consortium

17 March 202317 March 2023

AFRICA – The COVID Treatment Quick Start Consortium has announced that the governments of Zambia, Laos, Malawi and Rwanda have received shipments of PAXLOVID (nirmatrelvir/ritonavir), Pfizer’s COVID-19 oral treatment. Partners…

Read More

FDA advisory panel supports full approval of Pfizer’s COVID therapy

17 March 202317 March 2023

USA —Advisers to the U.S. Food and Drug Administration gave strong support for full approval of Pfizer’s oral antiviral COVID-19 treatment, Paxlovid, for adults at high risk of severe disease…

Read More

Posts navigation

Older posts

LATEST DIGITAL MAGAZINE

LATEST NEWS

  • UAE-based AstraGene and Mylab form joint venture to commercialize automated diagnostics
  • Chinese missionaries in Rwanda perform painless normal delivery
  • OSHCO, VAMED Group to establish a new rehabilitation & long-term care hospital in Riyadh
  • Uganda launches project to scale up paediatric surgical services in hospitals
  • Dubai’s state-owned DAHC, Pfizer, AXDEV Group ally to enhance chronic illness care

MOST POPULAR TAGS

Africa Africa CDC Artificial Intelligence AstraZeneca Cancer Covid-19 Diabetes Digital health Egypt France Germany Ghana GSK Healthcare Delivery HIV/AIDS Hospitals India Japan Johnson & Johnson Kenya Malaria Merck Mergers, Investments & Funding Middle East and North Africa Moderna MOH Kenya Nigeria Novartis Partnerships Pfizer Pharmaceuticals Public Health Roche Science & Technology South Africa Switzerland Tanzania UAE Uganda UK UNICEF USA US FDA Vaccines WHO

ARCHIVES

ABOUT FW AFRICA

We organise some of the most impactful face to face and virtual trade events and publish leading magazines and websites that bring Africa to the World and the World to Africa. We believe that when people come together, networks grow and businesses thrive.

Find more about us on our corporate website www.fwafrica.net

RELATED PUBLICATIONS

CEO Business Africa

Food Business Africa

Food Safety Africa

Milling & Baking Africa

Sustainable Packaging Africa

CONTACT US

FW Africa

P.O. Box 1874-00621, Nairobi, Kenya

Tel: +254 725 34 39 32

Email: info@fwafrica.net

Copyright © All rights reserved. FW Africa. We are not responsible for content from external sites.